Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01713075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1183
Last updated 2016-10-28
Summary
The purpose of the investigation is to confirm the safety and efficacy in long-term use of Symbicort Turbuhaler in patients with Chronic obstructive pulmonary disease (COPD) under the post-marketing actual use.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Shigeru Yoshida, MD · Astrazeneca KK
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Japan
Study Locations
More Related Trials
-
Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)
NCT00837629 ·Status: COMPLETED
-
Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease
NCT02157935 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01069289 ·Status: COMPLETED ·Phase: PHASE3
-
SYMBICORT® in the Treatment of COPD
NCT00564499 ·Status: COMPLETED
-
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)
NCT03197818 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)
NCT02497001 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01415518 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD
NCT00421122 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD
NCT00419744 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients
NCT00206154 ·Status: COMPLETED ·Phase: PHASE3
-
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)
NCT01253473 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®
NCT00542880 ·Status: COMPLETED ·Phase: PHASE4
-
Airway Clearance Study
NCT00379028 ·Status: COMPLETED ·Phase: PHASE4
-
Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients.
NCT01329276 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Symbicort ® on GR in Sputum in COPD
NCT01787097 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD
NCT00489853 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler
NCT01257048 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
NCT06154837 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison Between Symbicort® and Prednisolone in COPD
NCT00259779 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD
NCT02766608 ·Status: COMPLETED ·Phase: PHASE3
-
Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)
NCT03888131 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU
NCT00628862 ·Status: COMPLETED ·Phase: PHASE3
-
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT00422604 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo
NCT01760304 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Symbicort on the Ventilatory Kinematics
NCT01712854 ·Status: TERMINATED ·Phase: PHASE4